Strategies for immunoprophylaxis and immunotherapy of papillomaviruses
- 30 April 1997
- journal article
- Published by Elsevier in Clinics in Dermatology
- Vol. 15 (2) , 285-297
- https://doi.org/10.1016/s0738-081x(96)00151-4
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- T Cell Activation Determined by T Cell Receptor Number and Tunable ThresholdsScience, 1996
- Cimetidine therapy for warts: A placebo-controlled, double-blind studyJournal of the American Academy of Dermatology, 1996
- The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancerNature Medicine, 1995
- Serum Antibody against Unfused Recombinant E7 Protein of Human Papillomavirus Type 16 in Cervical Cancer PatientsJapanese Journal of Cancer Research, 1995
- Identification of a naturally processed HLA A0201‐restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoproteinEuropean Journal of Immunology, 1994
- Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patientsArchiv für die gesamte Virusforschung, 1994
- Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated CytotoxicityScience, 1994
- Treatment of Recurrent Respiratory Papillomatosis with Human Leukocyte InterferonNew England Journal of Medicine, 1988
- Interferon Therapy for Condylomata AcuminataNew England Journal of Medicine, 1986
- Versuche Über Immuntherapie der Warzen und KondylomeJournal of Molecular Medicine, 1925